Legend:
Figure 1. HV Skin Lesions in Sun-exposed Areas. Consent to publish photographs of the patient for the case report was obtained from the patient’s parent.
Figure 2. Bone marrow with lymphocytic infiltrate and scattered EBV-positive lymphocytes
Figure 3. Whole Blood and CSF EBV Levels by Day of Management with Interventions. Day 0 represents the initiation of systemic interventions with oral valganciclovir. Abbreviations: GCV, ganciclovir; DEX, dexamethasone; IT/IO HC/MTX, intrathecal/Intra-Ommaya hydrocortisone and methotrexate; BTZ, bortezomib; BSF, busulfan; PBSCs, peripheral blood stem cells; PTCy, post-transplantation cyclophosphamide.
Figure 4. Angiography at 6 Months Prior to HSCT shows severely dilated RCA with low flow in the RCA, left anterior descending artery with multiple aneurysms with a beaded appearance, and circumflex artery with multiple large aneurysms.
Figure 5. CTA performed day +213 after HSCT demonstrates Middle Cerebral Artery Aneurysm
Figure 6. Flow-diverting Stent with Aneurysm Coiling
Figure 7. Head CT day +235 after HSCT demonstrates massive diffuse subarachnoid hemorrhage with right frontal lobe hemorrhage and hemorrhage into the ventricular system.
Figure 1.